2 recruiting, 1 completed, 1 enrolling by invitation, 1 unknown. 2 Phase 4, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 2 |
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Acute Tubulointerstitial Nephritis: new trials by email Literature Review of Acute Tubulointerstitial Nephritis trials Research Report on Acute Tubulointerstitial Nephritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Infliximab for Immune Checkpoint Inhibitor Associated AKI Infliximab, Prednisone, prednisone (oral) - Acute Kidney Injury, Acute Interstitial Nephritis | Phase 4 | Recruiting | Massachusetts General Hospital | 44 | 2026-09-15 | 2026-10-09 |
| Identification of the Causative Drug in Drug-induced Acute Interstitial Nephritis in vitro Allergological test Allergological skin tests - Acute Interstitial Nephritis, Drug-Induced Interstitial Nephritis | Not applicable | Unknown | Assistance Publique - Hôpitaux de Paris | 44 | 2022-07-01 | 2022-06-30 |
| Biorepository to Support Research in Kidney Diseases Acute Kidney Injury, Acute Interstitial Nephritis | Enrolling by invitation | Yale University | 1000 | 2020-07-28 | 2025-08-13 | |
| Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN) Omalizumab, Prednisone - Acute Interstitial Nephritis | Phase 2 | Withdrawn | Mayo Clinic | 2018-06-01 | 2018-12-06 | |
| Prednisolone Treatment in Acute Interstitial Nephritis Prednisone - Acute Tubulo-Interstitial Nephritis | Phase 4 | Recruiting | Region MidtJylland Denmark | 110 | 2017-09-01 | 2020-12-30 |
| Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists Hospitalized Cases of Angioneurotic Oedema, Pneumonia | Completed | AstraZeneca | 23470 | 2011-05-01 | 2016-08-10 |
Acute Kidney Injury (2) · Kidney Diseases (2) · Failure to Thrive (1) · Gastroenteritis (1) · Hypersensitivity (1) · Nephritis (1) · Nephritis, Interstitial (1) · Pneumonia (1) · Seizures (1) · Thrombocytopenia (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Renal Insufficiency (2) · Blood Platelet Disorders (1) · Cytopenia (1) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Infections (1) · Kidney Diseases (1)
Prednisone (3) · Prednisolone (2) · Blood Specimen Collection (1) · Infliximab (1) · Omalizumab (1)
Assistance Publique - Hôpitaux de Paris (1) · AstraZeneca (1) · Massachusetts General Hospital (1) · Mayo Clinic (1) · Region MidtJylland Denmark (1) · Yale University (1)
United States (3) · Denmark (1) · France (1) · Netherlands (1)
David Leaf, MD (1) · Dennis G Moledina, MD (1) · Jesper N Bech, MD (1) · Leanne M.A. Houweling, MSc (1) · Meghan E Sise, MD (1) · Ron M.C. Herings, PhD (1) · Vesna D. Garovic, M.D. (1)
PMID 28562108, PMID 29149805, PMID 33933012
K23DK117065 (1), R01DK128087 (1), R01DK144161 (1)